SCI & TECH● LOWAug 19 · Aug 19, 2026, 10:59 AM
Moderna, Merck rise after late-stage trial win for mRNA cancer therapy
Seeking Alpha Tech
Pharmaceutical companies Moderna and Merck saw their stock rise after a successful late-stage trial for their mRNA cancer therapy, indicating progress in cancer treatment and potential market impact.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH35m agoMoonshot AI resets Kimi K3.1 Pro quotas after user complaintsSeeking Alpha TechSCI & TECH53m agoBe nice, not nasty: Nobel laureate Geoffrey Hinton on why AI needs humans at its heartEuroNews [en]SCI & TECH1h agoBooks and AI: how the new human authorship certificates workClarínSCI & TECH1h ago'Pure garbage': Elon Musk’s AI-generated 'The Odyssey' clip ridiculed onlineEuroNews [en]